TMEM37 and bladder transitional cell carcinoma: Only one study reported that ciglitazone exhibited inhibitory effects on cell number in a series of cell lines modelling metastatic transitional cell carcinoma of the bladder (TSU-Pr1, TSU-Pr1-B1 and TSU-Pr1-B2) [6].